Cytotoxic and Radiosensitising Effects of a Novel Thioredoxin Reductase Inhibitor in Brain Cancers

The thioredoxin (Trx) system, a key antioxidant pathway, represents an attractive target for cancer therapy. This study investigated the chemotherapeutic and radiosensitising effects of a novel Trx reductase (TrxR) inhibitor, IQ10, on brain cancer cells and the underlying mechanisms of action. Five...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Anqi, Storr, Sarah J., Inman, Martyn, Barwell, Lucy, Moody, Christopher J., Martin, Stewart G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148287/
https://www.ncbi.nlm.nih.gov/pubmed/35344158
http://dx.doi.org/10.1007/s12035-022-02808-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148287/
https://www.ncbi.nlm.nih.gov/pubmed/35344158
http://dx.doi.org/10.1007/s12035-022-02808-4

Ejemplares similares